Why an at-home test for multiple viruses can wait!
Swabbing ourselves has become common. At home, Covid-19 tests were made so convenient that people could stay home and find out if they were positive in a matter of 15 minutes. Having that convenience of being able to do the same with other contagious illnesses such as the flu and RSV would be extremely beneficial […]
Read More
What You Need To Know About Lyme Disease
Lyme Disease is one of the most common diseases transmitted by an insect bite in the United States. After a tick attaches itself to a host, it can take up to 24-36 hours for the tick to infect the body with Lyme disease. Once infected, people will usually start having flu-like symptoms such as headaches, […]
Read More
Know What You’re Up Against With RSV
Hospitals around the country are seeing a rise in RSV (respiratory syncytial virus) cases this season, especially among pediatric patients. RSV is a respiratory virus that attacks the lungs and can be very dangerous in older adults and infants who have weakened immune systems. It is known as a highly infectious virus and can sometimes […]
Read More
Why It Is Important To Get Your Flu Shot This Year!
The flu virtually disappeared for two years as the pandemic raged. But influenza appears poised to stage a comeback this year in the United States, according to public health officials. The flu season has started early, and may be severe based on data the CDC reports weekly. The number of flu cases are already on […]
Read More
Seasonal Killers Have a New Foe
Better Protection against Flu and RSV – mRNA Technology is a Game Changer in vaccine trials at Rochester Clinical Research Rochester Clinical Research (RCR) is currently studying mRNA vaccine development for infectious diseases such as Influenza (Flu) and RSV. The COVID pandemic put mRNA technology on a fast track, creating significant opportunities to change how […]
Read More
RCR Helps with Acute Migraine Treatment Advancements!
Rochester Clinical Research is proud to have worked on the BioHaven studies that show promise in treating acute migraines with a receptor antagonist known as Zavegepant. BioHaven Pharmaceuticals has been working on this investigational nasal spray that is now in phase 3 of development and is the only one of its kind that is close […]
Read More
Set Goals, and Not Limits When it Comes to Weight Loss
Rochester Clinical Research is proud to have worked on the Tirzepatide drug clinical trials over the past few years. We have enrolled over 32 subjects over 2 different studies that have led to the newest findings for this new cutting-edge drug. Study data has been released and shows that it has so far been proven […]
Read MoreCutting-Edge Care Options Now More Accessible for Patients
Rochester Clinical Research Offers Solutions to Regional Care Providers Rochester Clinical Research (RCR) has announced the launch of their Community Research Division (RCRCD). RCR is a leading clinical research facility in Western New York with well established relationships with pharmaceutical, vaccine and device companies. The new division will bring the value of clinical research as […]
Read More#HealthHistory- Dr. Marilyn Hughes Gaston
#HealthHistory Celebrating revolutionary individuals who made historical advancements in medicine Dr. Marilyn Hughes Gaston was a medical trailblazer who broke barriers and shattered stereotypes within the medical community. She conducted research, created treatments, and provided medical leadership in pediatric medicine but, most importantly in the world of Sickle Cell Disease (SCD). Her goal in becoming a […]
Read MoreA revolutionary therapy to lower bad cholesterol.
A revolutionary therapy to lower bad cholesterol, Leqvio (Inclisiran), has been approved by the US Food and Drug Administration (FDA) as well as the European Commission (EC). Leqvio is the first and only approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol) reduction. In studies, Leqvio showed LDL-C reduction of up to 52% when […]
Read More